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Meningococcal Disease in Burkina Faso and Elsewhere
According to the WHO report of 19 March 2007 (http://www.who.int/csr/don/2007_03_19a/en/index.html), the Ministry of
Health of Burkina Faso reported 7333 suspected cases of meningococcal disease between 1 January and 11 March 2007. There
had been a total of 583 deaths reported, which produced a case-fatality of 8%. The number of cases in twenty-two districts
(including three districts in the capital, Ouagadougou) are over the epidemic threshold.
The Ministry of Health of Burkina Faso is being supported by WHO, Me´decins sans Frontie`res, Plan Burkina, and UNICEF in the
management of this outbreak, due to Neisseria meningitidis serogroup A. The main strategy is large scale vaccination. The first
phase of a vaccination campaign targeting 1 million people has been completed in six districts and is on-going in a further two
districts. The above organisations are providing technical and/or financial support to the Ministry of Health. However, it is
estimated that more than US$ 1.2 million are still urgently needed to allow the necessary vaccination campaigns in Burkina
Faso to be implemented in full.
ProMED Mail provides regular updates on Meningococcal disease. The posting on 20 March 2007 (ProMED Mail Archive Number
20070320.0977) described the situation in Uganda, and the posting on 16 March 2007 (ProMED Mail Archive Number
20070316.0934) covered Burkina Faso, Congo DR, Sudan and Uganda.
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During the weekend of 10—11 March 2007, ten newborn babies died on the neonatology ward at the Mario Rivas hospital in Sao
Pedro Sula, the second largest city in Honduras (ProMED Mail Archive Number 20070316.0931). The cause of the deaths was
infection with antibiotic resistant Serratia marcescens, and officials at this hospital closed the ward. Among the babies who
died that weekend were a set of triplets and a set of quintuplets. According to the latest reports (16 March 2007), no other
babies had died as a result of this infection since 11 March.
The acting director of the hospital, the neonatologist Samuel Santos, confirmed that between 16 January 2007 and the
weekend of the 10—11 March, at least eleven babies had died as a result of Serratia infection. A further six deaths are being
investigated.
This outbreak is being investigated by epidemiologists and other experts from the Public Health Ministry of Honduras.
According to reports from the hospital, an antibiotic resistant strain of Serratia marcescens had been cultured from hospital
water systems, personnel, and hospital facilities over the last two years. There have been previous reports of outbreaks of
Serratia due to contamination of solutions used in health care (e.g. ProMED Mail Archive Number 20050320.0808). Whether this
has contributed to this outbreak is unclear. Further reports are awaited.E-mail address: fiona.cooke@imperial.ac.uk (F.J. Cooke), dan@promedmail.org (D.S. Shapiro).
1201-9712/$32.00
doi:10.1016/S1201-9712(07)00051-3
190 ProMED updateRift Valley Fever: TanzaniaRift Valley fever (RVF), a mosquito-borne disease that is in the Bunyaviridae family and the Phlebovirus genus, has caused a
total of 18 deaths in Tanzania as of 22 March 2007 [ProMED Mail Archive Number 20070323.1020]. Earlier that week, according
to the Tanzanian Health Minister, David Mwakyusa, in addition to deaths due to RVF, a total of 79 people were suspected to
have been infected with RVF. The deaths and suspected cases included the Arusha, Dodoma, Manyara, and Tanga regions of
Tanzania. The disease in humans is the result of either direct contact with tissue, body fluids, or blood from infected animals
(including sheep, cattle, and other livestock) or as the result of mosquito bites. It may be that contaminated aerosols also
transmit the virus.
Prior to the outbreak in Tanzania, there was an outbreak of RVF in neighboring Kenya. Of note, the RVF virus was first isolated in
1931 in the Rift Valley of Kenya when lambs and sheep were ill with this zoonotic pathogen. Clinically, RVF in humans most
often presents as in influenza-like infection. Complications, however, include meningoencephalitis, retinitis (which may cause
a permanent loss of central vision), or hemorrhagic fever, which is frequently fatal.
